Application Nr Approved Date Route Status External Links
NDA022185 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Calcipotriene And Betamethasone Dipropionate Topical Suspension Is Indicated For The Topical Treatment Of Plaque Psoriasis Of The Scalp And Body In Patients 12 Years And Older. Calcipotriene And Betamethasone Dipropionate Topical Suspension Is A Combination Of Calcipotriene, A Vitamin D Analog, And Betamethasone Dipropionate, A Corticosteroid, Indicated For The Topical Treatment Of Plaque Psoriasis Of The Scalp And Body In Patients 12 Years And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Betamethasone Dipropionate BETAMETHASONE DIPROPIONATE ZINC3876136
2. Calcipotriene Hydrate

Comments